Home workouts could speed lung cancer recovery, new study says
NCT ID NCT07478276
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a home-based program of exercise and breathing techniques for people with lung cancer who are scheduled for surgery. The program lasts 8 weeks before surgery and 4 weeks after, using a smartphone app to guide patients. Researchers want to see if it improves fitness, reduces complications, and speeds recovery compared to standard care. About 84 adults with operable lung cancer will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2028
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years. 2. Histological or cytological diagnosis of lung cancer (resectable stage according to the multidisciplinary team). 3. Patients scheduled for lung surgery with curative intent (lobectomy, segmentectomy, pneumonectomy, etc.). 4. Ability to understand and sign informed consent. 5. Clinical condition that allows participation in a supervised exercise program, according to medical evaluation, with an ECOG performance status of 0-2 (Eastern Cooperative Oncology Group Performance Status). 6. Availability to perform the scheduled measurements and follow-ups (preoperative and postoperative). 7. Ability to use the mobile application or have family support to do so. Exclusion Criteria: 1\. Absolute medical contraindications to supervised physical exercise, such as unstable angina, recent decompensated heart failure, uncontrolled arrhythmias, or acute cardiovascular events within the last 3 months. 2\. Very advanced chronic lung disease that prevents participation in the program (e.g., severe COPD with FEV1 \< 30% predicted, as determined by the clinical team). 3\. Distant metastases or metastatic cancer that contraindicate surgery with curative intent. 4\. Planned palliative surgery or life expectancy \< 3 months. 5\. Home oxygen therapy with severe, uncorrectable hypoxemia, as determined by clinical judgment. 6\. Moderate-to-severe cognitive, neurological, or psychiatric impairment that prevents understanding of the study or proper use of the mobile application. 7. An insurmountable language barrier that prevents understanding the study information or using the mobile application. 8\. Pregnancy. 9\. Participation in another interventional clinical trial that may interfere with the study objectives or its primary outcome. 10\. Any other condition that, in the opinion of the research team, compromises the participant's safety or adherence to the protocol. Withdrawal Criteria 1. Withdrawal of consent. 2. Adverse events that contraindicate continued exercise (clinical decision). 3. Failure to complete more than 30% of planned sessions (for per-protocol analysis; continue in ITT).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Surgeons could freeze lung tumors from miles away using 5G robots
- Can AI make lung cancer scans easier to read?
- Two-Drug combo targets Treatment-Resistant lung cancer
- Can an Anti-Fibrotic drug shield lungs from radiation after immunotherapy?
- App aims to catch a hidden radiotherapy side effect
- Which nerve block wins for lung surgery pain?